000 | 01041 a2200277 4500 | ||
---|---|---|---|
005 | 20250514071438.0 | ||
264 | 0 | _c20031014 | |
008 | 200310s 0 0 eng d | ||
022 | _a0272-8087 | ||
024 | 7 |
_a10.1055/s-2003-39949 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSulkowski, Mark S | |
245 | 0 | 0 |
_aHepatotoxicity associated with antiretroviral therapy containing HIV-1 protease inhibitors. _h[electronic resource] |
260 |
_bSeminars in liver disease _cMay 2003 |
||
300 |
_a183-94 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xadverse effects |
650 | 0 | 4 |
_aHIV Protease Inhibitors _xadverse effects |
650 | 0 | 4 | _aHepatitis B |
650 | 0 | 4 |
_aHepatitis C _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver _xdrug effects |
773 | 0 |
_tSeminars in liver disease _gvol. 23 _gno. 2 _gp. 183-94 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-2003-39949 _zAvailable from publisher's website |
999 |
_c12584586 _d12584586 |